
Article content
Investment establishes Malar as strategic partner as the clinically-dosed wellness brand prepares its next phase of growth and global expansion.
THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
SUBSCRIBE TO UNLOCK MORE ARTICLES
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
REGISTER / SIGN IN TO UNLOCK MORE ARTICLES
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account.
- Share your thoughts and join the conversation in the comments.
- Enjoy additional articles per month.
- Get email updates from your favourite authors.
THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account
- Share your thoughts and join the conversation in the comments
- Enjoy additional articles per month
- Get email updates from your favourite authors
Sign In or Create an Account
or
Article content
TORONTO — Malar Group, the investment firm founded and led by Sayan Navaratnam, today announced it has closed the Friends & Family round of Attaboy Labs, Inc., the wellness brand behind the clinically-dosed daily supplement Every Damn Day. The investment combines capital with a long-term strategic partnership focused on scaling Attaboy into a global consumer brand.
Article content
Article content
Article content
Founded by Nick Lawhon, Attaboy Labs has built a differentiated position in a crowded wellness category by leading with formulation rather than marketing. Every Damn Day combines creatine, electrolytes, and cognitive-support ingredients — all at clinical doses, with no proprietary blends and no caffeine — into a single daily serving. The product is third-party tested and fully transparent in its labeling.
Article content
By signing up you consent to receive the above newsletter from Postmedia Network Inc.
Article content
The investment establishes Malar as a strategic partner in Attaboy’s next phase — supporting product development, international expansion, and broader ecosystem access across Malar’s portfolio and partner network. For Malar, the investment extends a pattern of backing founder-led brands building category-defining positions.
Article content
“The Malar Group isn’t just closing our Friends & Family round — they’re joining us as a strategic partner as we build Attaboy into a global supplement brand,” said Nick Lawhon, Founder and CEO of Attaboy Labs, Inc. “Their commitment reflects shared conviction that clinically-dosed, transparent wellness products deserve a much bigger stage. We’re funded, we’re focused, and we’re ready to scale.”
Article content
“Most of what we see in the wellness space is marketing in search of a product. Attaboy is the opposite,” said Sayan Navaratnam, Founder and CEO of Malar Group. “Clinically-dosed formulations, full ingredient transparency, and a loyal base of customers who actually use the product every day — that’s a real business. Nick has built something with genuine conviction behind it, and our job is to help him take it global, starting here at home in Canada.”
Article content
Attaboy will use the investment to expand its product roadmap, accelerate customer acquisition, and prepare for Canadian market entry, with broader international expansion to follow.
Article content
About Attaboy Labs
Article content
Attaboy Labs is a wellness brand built on clinically-dosed, transparent formulations. Its flagship product, Every Damn Day, is a once-daily supplement designed to support energy, focus, strength, recovery, and hydration without caffeine or proprietary blends. Attaboy’s products are third-party tested and made in Utah with globally sourced, high-quality ingredients. The brand serves a rapidly growing base of customers across North America. Learn more at attaboylabs.com.
Article content
About Malar Group
Article content
Malar Group is an investment firm founded and led by Sayan Navaratnam. The firm invests in technology-driven companies and high-conviction consumer brands across industries, with an emphasis on long-term strategic partnership, operator access, and global scaling support. Learn more at malargroup.com.
Article content
Article content
Article content
View source version on businesswire.com:
Article content
Article content

Article content
Contacts
Article content
Media
Article content
Article content
Attaboy Labs, Inc.
Article content
Article content
Nick Lawhon, Founder & CEO
Article content
Article content
Article content
Malar Group
Article content
Article content
Umar Qureshi, Media Relations
Article content
Article content
Article content

1 hour ago
3
English (US)